Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2021-12-03 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
INSIDE INFORMATION - BUSINESS UPDATES
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to the Listing Rules of the Hong Kong Stock Exchange and the Securities and Futures Ordinance. It provides business updates about the inclusion of two innovative medicines in the National Reimbursement Drug List by the National Healthcare Security Administration of China. The document contains no financial statements or detailed financial analysis, nor does it present quarterly or annual financial results. It is not a report of voting results, management changes, or legal proceedings. The document is a regulatory announcement providing material business information to the market, consistent with an 'Inside Information' announcement under Hong Kong Listing Rules. It is not a full report or presentation but a regulatory filing informing the market of significant business developments. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-12-03 English
Documents on Display
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2021-12-02 English
Notification Letter and Request Form to Non-Registered Holders - Notice of Publication of Extraordinary General Meeting Circular ("Current Corporate Communications")
Report Publication Announcement Classification · 95% confidence The document is a notification letter from RemeGen Co., Ltd. addressed to non-registered shareholders regarding the publication of an Extraordinary General Meeting (EGM) circular. It provides instructions on how shareholders can access the circular electronically or request a printed version. The document includes a request form for shareholders to specify their preferred language and format for receiving corporate communications. There is no substantive financial data, analysis, or detailed report content present. The document is essentially an announcement about the availability of a corporate communication (the EGM circular) rather than the circular itself or any financial report. Therefore, it fits the category of a Report Publication Announcement (RPA), which covers announcements regarding the timing, release, or publication of company reports or communications.
2021-12-02 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for RemeGen Co., Ltd. It includes details about the meeting date, location, agenda (approval of a strategic allotment), proxy voting instructions, and shareholder information. There is no financial data, management discussion, or detailed report content. The document is a formal meeting notice rather than a report or announcement of voting results. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings, including extraordinary ones.
2021-12-02 English
PROXY FORM FOR USE AT THE 2021 THIRD EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use at the 2021 third extraordinary general meeting of RemeGen Co., Ltd. It contains instructions for shareholders to appoint proxies to vote on resolutions at the meeting. This type of document is used to solicit votes from shareholders and is not a report of voting results or the meeting itself. It is a solicitation material related to a shareholder meeting, specifically a proxy solicitation form. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 6616 characters, which is consistent with a detailed proxy form rather than a brief announcement or a full report.
2021-12-02 English
CONNECTED TRANSACTION - PARTICIPATION IN STRATEGIC ALLOTMENT UNDER THE ISSUE OF A SHARES BY CONNECTED PERSONS AND NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by RemeGen Co., Ltd. regarding a connected transaction involving participation in a strategic allotment under the issue of A shares by connected persons. It includes a notice of an Extraordinary General Meeting (EGM) to be held for shareholders to consider and approve this transaction. The document contains detailed information such as definitions, letters from the board, independent board committee, and independent financial adviser, and a proxy form for the EGM. It is not a financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a circular providing information and notice of the EGM related to a connected transaction and strategic allotment. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings, especially for connected transactions and share allotments requiring shareholder approval.
2021-12-02 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.